Windtree Therapeutics, Inc. (WINT) to Explore Strategic Alternatives Jan 31, 2024 08:04AM
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives Jan 31, 2024 08:00AM
Windtree Therapeutics Announces Closing of $12.42 Million Underwritten Public Offering Including Full Exercise of Overallotment Option Apr 24, 2023 04:01PM
Windtree Therapeutics, Inc. (WINT) Prices Upsized $10.8 Million Underwritten Public Offering of Common Stock, Warrants Apr 20, 2023 08:34AM
Windtree Therapeutics Announces Pricing of Upsized $10.8 Million Underwritten Public Offering Apr 20, 2023 08:30AM


Jan 20, 2023 08:38AM Windtree Therapeutics, Inc. (WINT) Raises $1M from Warrant Exercise
Jan 20, 2023 08:37AM  Windtree Therapeutics to Raise $1.0 Million From the Exercise of Previously Issued Warrants
Nov 14, 2022 07:30AM Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
Sep 21, 2022 04:05PM Windtree to Present at the Ladenburg Thalmann Healthcare Conference
Aug 5, 2021 04:01PM Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates
Jul 7, 2021 07:30AM Windtree to Present at the Ladenburg Thalmann 2021 Healthcare Conference (Virtual)
Mar 25, 2021 04:15PM Windtree Therapeutics Announces Closing of $30.0 Million Public Offering
Mar 23, 2021 08:33AM Windtree Therapeutics, Inc. (WINT) Prices 9.23M Share Common Offering at $3.25/Sh
Mar 23, 2021 08:30AM Windtree Therapeutics Announces Pricing of $30.0 Million Public Offering
Mar 22, 2021 04:06PM Windtree Therapeutics, Inc. (WINT) to Offer Common Stock
Mar 22, 2021 04:05PM Windtree Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
Jun 26, 2020 06:49AM UPDATE: Ladenburg Thalmann Starts Windtree Therapeutics (WINT) at Buy
May 22, 2020 04:05PM Windtree Therapeutics Announces Closing of $23 Million Public Offering Including Full Exercise of Over-Allotment Option
May 20, 2020 08:35AM Windtree Therapeutics, Inc. (WINT) Prices 2.758M Unit Common Offering at $7.25/Unit; Announces Uplisting to Nasdaq
May 20, 2020 08:30AM Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market